Document is current
Any future updates will be listed below
-
Authors
Zhao, Xutong http://orcid.org/0000-0003-3179-7369
Qiao, Dandi
Yang, Chaojie
Kasela, Silva http://orcid.org/0000-0003-4362-0034
Kim, Wonji
Ma, Yanlin
Shrine, Nick http://orcid.org/0000-0003-3641-4371
Batini, Chiara
Sofer, Tamar http://orcid.org/0000-0001-8520-8860
Taliun, Sarah A. Gagliano http://orcid.org/0000-0003-1306-1868
Sakornsakolpat, Phuwanat http://orcid.org/0000-0002-4308-0974
Balte, Pallavi P.
Prokopenko, Dmitry
Yu, Bing
Lange, Leslie A.
Dupuis, Josée http://orcid.org/0000-0003-2871-3603
Cade, Brian E. http://orcid.org/0000-0003-1424-0673
Lee, Jiwon http://orcid.org/0000-0002-4079-7494
Gharib, Sina A.
Daya, Michelle http://orcid.org/0000-0002-9057-6593
Laurie, Cecelia A. http://orcid.org/0000-0001-6569-2501
Ruczinski, Ingo
Cupples, L. Adrienne http://orcid.org/0000-0003-0273-7965
Loehr, Laura R.
Bartz, Traci M.
Morrison, Alanna C.
Psaty, Bruce M.
Vasan, Ramachandran S. http://orcid.org/0000-0001-7357-5970
Wilson, James G.
Taylor, Kent D. http://orcid.org/0000-0002-2756-4370
Durda, Peter
Johnson, W. Craig
Cornell, Elaine
Guo, Xiuqing
Liu, Yongmei
Tracy, Russell P. http://orcid.org/0000-0002-0080-2420
Ardlie, Kristin G.
Aguet, François http://orcid.org/0000-0001-9414-300X
VanDenBerg, David J. http://orcid.org/0000-0002-5404-5218
Papanicolaou, George J.
Rotter, Jerome I. http://orcid.org/0000-0001-7191-1723
Barnes, Kathleen C. http://orcid.org/0000-0002-3030-4705
Jain, Deepti
Nickerson, Deborah A.
Muzny, Donna M.
Metcalf, Ginger A.
Doddapaneni, Harshavardhan http://orcid.org/0000-0002-2433-633X
Dugan-Perez, Shannon
Gupta, Namrata
Gabriel, Stacey
Rich, Stephen S. http://orcid.org/0000-0003-3872-7793
O’Connor, George T.
Redline, Susan
Reed, Robert M.
Laurie, Cathy C.
Daviglus, Martha L.
Preudhomme, Liana K.
Burkart, Kristin M.
Kaplan, Robert C.
Wain, Louise V. http://orcid.org/0000-0003-4951-1867
Tobin, Martin D.
London, Stephanie J. http://orcid.org/0000-0003-4911-5290
Lappalainen, Tuuli http://orcid.org/0000-0002-7746-8109
Oelsner, Elizabeth C.
Abecasis, Goncalo R. http://orcid.org/0000-0003-1509-1825
Silverman, Edwin K.
Barr, R. Graham
,
,
Cho, Michael H. http://orcid.org/0000-0002-4907-1657
Manichaikul, Ani http://orcid.org/0000-0002-5998-795X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K01-HL129039, R01 HL142028, HHSN2682015000031/HHSN26800004, R01-HL142028, U01-HL117626, R01 HL135142, R01 HL137927, R01 HL089856, R01 HL147148, R01 HL131565)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- License Information
-
More Information
Article History
Received: 6 January 2020
Accepted: 19 August 2020
First Online: 14 October 2020
Competing interests
: In the past three years, Edwin K. Silverman and Michael H. Cho have received grant and travel support from GlaxoSmithKline and Bayer. Michael H. Cho has received consulting and speaking fees from Illumina and AstraZeneca. Tuuli Lappalainen is a scientific advisory board member of Variant Bio with equity and Goldfinch Bio. Bruce M. Psaty serves on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. Goncalo R. Abecasis is an employee of Regeneron Pharmaceuticals and owns stock and stock options for Regeneron Pharmaceuticals. All other authors have no competing interests to declare.
